(Q36194308)

12 August 2017

Radical prostatectomy versus observation for localized prostate cancer (English)

1 reference

12 August 2017

1 reference

15

Claus Roehrborn

1 reference

12 August 2017

Timothy J Wilt

1

1 reference

12 August 2017

Michael K Brawer

2

1 reference

12 August 2017

Karen M Jones

3

1 reference

12 August 2017

Michael J Barry

4

1 reference

12 August 2017

William J Aronson

5

1 reference

12 August 2017

Steven Fox

6

1 reference

12 August 2017

Jeffrey R Gingrich

7

1 reference

12 August 2017

John T Wei

8

1 reference

12 August 2017

Patricia Gilhooly

9

1 reference

12 August 2017

B Mayer Grob

10

1 reference

12 August 2017

Imad Nsouli

11

1 reference

12 August 2017

Padmini Iyer

12

1 reference

12 August 2017

Ruben Cartagena

13

1 reference

12 August 2017

Glenn Snider

14

1 reference

12 August 2017

Roohollah Sharifi

16

1 reference

12 August 2017

William Blank

17

1 reference

12 August 2017

Parikshit Pandya

18

1 reference

12 August 2017

Gerald L Andriole

19

1 reference

12 August 2017

Daniel Culkin

20

1 reference

12 August 2017

Thomas Wheeler

21

1 reference

12 August 2017

Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group

22

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

12 August 2017

11

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

12 August 2017

367

1 reference

12 August 2017

203-213

1 reference

12 August 2017

3

1 reference

Prostate-cancer mortality at 11 years of follow-up

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Time trends and local variation in primary treatment of localized prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Outcomes of localized prostate cancer following conservative management

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Contemporary risk profile of prostate cancer in the United States

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Contemporary trends in low risk prostate cancer: risk assessment and treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Assessment of endpoints for clinical trials for localized prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Active surveillance for prostate cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Prostate cancer and the Will Rogers phenomenon.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Radical prostatectomy versus watchful waiting in early prostate cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429335

Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort

21 October 2018

1 reference

12 December 2020

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

12 December 2020

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

12 December 2020

Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study

1 reference

12 December 2020

Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis

1 reference

12 December 2020

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

12 December 2020

The Actual Value of the Surgical Margin Status as a Predictor of Disease Progression in Men with Early Prostate Cancer

1 reference

12 December 2020

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

12 December 2020

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically

1 reference

12 December 2020

Trials of prostate-cancer screening are not worthwhile

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1113162

1 reference

12 August 2017

1 reference

12 August 2017

1 reference